98 related articles for article (PubMed ID: 8104120)
1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
Dubois N; Lapicque F; Maurice MH; Pritchard M; Fournel-Gigleux S; Magdalou J; Abiteboul M; Siest G; Netter P
Drug Metab Dispos; 1993; 21(4):617-23. PubMed ID: 8104120
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
Dubois-Presle N; Lapicque F; Maurice MH; Fournel-Gigleux S; Magdalou J; Abiteboul M; Siest G; Netter P
Mol Pharmacol; 1995 Mar; 47(3):647-53. PubMed ID: 7700262
[TBL] [Abstract][Full Text] [Related]
3. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.
Sallustio BC; Fairchild BA; Pannall PR
Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
Presle N; Lapicque F; Fournel-Gigleux S; Magdalou J; Netter P
Drug Metab Dispos; 1996 Oct; 24(10):1050-7. PubMed ID: 8894504
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein.
Volland C; Sun H; Dammeyer J; Benet LZ
Drug Metab Dispos; 1991; 19(6):1080-6. PubMed ID: 1687014
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo irreversible plasma protein binding of beclobric acid enantiomers.
Mayer S; Mutschler E; Benet LZ; Sphahn-Langguth H
Chirality; 1993; 5(3):120-5. PubMed ID: 8338721
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective interactions of ketoprofen glucuronides with human plasma protein and serum albumin.
Hayball PJ; Nation RL; Bochner F
Biochem Pharmacol; 1992 Jul; 44(2):291-9. PubMed ID: 1642643
[TBL] [Abstract][Full Text] [Related]
8. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
9. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma.
Bailey MJ; Dickinson RG
Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513
[TBL] [Abstract][Full Text] [Related]
10. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism.
Smith PC; Benet LZ; McDonagh AF
Drug Metab Dispos; 1990; 18(5):639-44. PubMed ID: 1981713
[TBL] [Abstract][Full Text] [Related]
11. Plasma protein binding of ketoprofen enantiomers in man: method development and its application.
Hayball PJ; Nation RL; Bochner F; Newton JL; Massy-Westropp RA; Hamon DP
Chirality; 1991; 3(6):460-6. PubMed ID: 1812956
[TBL] [Abstract][Full Text] [Related]
12. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
Liu JH; Malone RS; Stallings H; Smith PC
J Pharmacol Exp Ther; 1996 Jul; 278(1):277-83. PubMed ID: 8764361
[TBL] [Abstract][Full Text] [Related]
13. Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the rhesus monkey and in vitro with human serum albumin.
Castillo M; Smith PC
Drug Metab Dispos; 1995 May; 23(5):566-72. PubMed ID: 7587932
[TBL] [Abstract][Full Text] [Related]
14. In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acids.
Georges H; Presle N; Buronfosse T; Fournel-Gigleux S; Netter P; Magdalou J; Lapicque F
Chirality; 2000 Feb; 12(2):53-62. PubMed ID: 10637410
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
Dubois N; Lapicque F; Abiteboul M; Netter P
Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
[TBL] [Abstract][Full Text] [Related]
16. Stereospecific pH-dependent degradation kinetics of R- and S-naproxen-beta-l-O-acyl-glucuronide.
Mortensen RW; Sidelmann UG; Tjørnelund J; Hansen SH
Chirality; 2002 May; 14(4):305-12. PubMed ID: 11968070
[TBL] [Abstract][Full Text] [Related]
17. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
Bednarski PJ; Kratochwil NA; Otto AM
Drug Metab Dispos; 1994; 22(3):419-27. PubMed ID: 7520852
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of ketoprofen.
Levoin N; Blondeau C; Guillaume C; Grandcolas L; Chretien F; Jouzeau JY; Benoit E; Chapleur Y; Netter P; Lapicque F
Biochem Pharmacol; 2004 Nov; 68(10):1957-69. PubMed ID: 15476667
[TBL] [Abstract][Full Text] [Related]
20. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
Smith PC; McDonagh AF; Benet LZ
J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
